News
A new outer membrane vesicle-based vaccine platform offers a simpler approach to antigen display by leveraging the expression of a Synthetic Antigen-Binding Protein (SNAP) to easily enable the docking of various biotinylated antigens.
News
Learn how scientists at the Pritzker School of Molecular Engineering, University of Chicago, have engineered a masked Interleukin-12 protein that is preferentially unmasked at tumor sites, thereby reducing adverse events commonly associated with systemic
News
Learn about molecular mechanisms underscoring Dystroglycanopathies, a type of muscular dystrophy, and a new AAV-based gene replacement strategy to restore muscle function and reduce pathology.
News
Learn about NAFLD and NASH chronic liver disease states and how an AAV8 delivered E06-scfv helps reduce pathogenesis by targeting oxidized phospholipids.
News
Learn how scientists at the University of Pennsylvania and Moderna are advancing the production and delivery of effective mRNA therapeutics.
News
Learn how a new Claudin 6 CAR T immunotherapy strategy leverages a Claudin6 mRNA nanoparticle vaccine to boost the efficacy of cell therapy against solid tumors.
Resource
Learn about a new cell therapy strategy under clinical evaluation that leverages Cardiosphere-derived cells (CDCs) to reduce the progression of cardiac and skeletal myopathy in DMD patients.
Resource
Advancing mRNA Medicines: Progressing Beyond Vaccines to Immunotherapies
News
NGS has reduced cost and accelerated DNA sequencing, but Sanger sequencing continues to be ideal for routine low volume synthetic DNA and plasmid sequencing.
Blog
Learn about GenScript’s manufacturing facility in the USA, which will offer fully automated gene synthesis and sequencing services.